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AbstrACt
Introduction Short screenings of alcohol-related 
dependence are needed for population-based 
assessments. A clinical interview constitutes a reliable 
diagnosis often seen as gold standard, but it is costly 
and time consuming and as such, not suitable for 
population-based assessments. Therefore, self-reported 
questionnaires are needed (eg, alcohol use disorder 
(AUD) as in the Diagnostic and Statistic Manual of Mental 
Disorders (DSM) 5), but their reliability is questionable. 
Recent studies called for more evidence-based 
measurements for population-based screening (eg, heavy 
alcohol use over time (HAU)). This study aims to test the 
reliability of different self-reported measures of alcohol 
use.
Methods and analysis Based on stratified random 
selection, 280 participants will be recruited from the 
French-speaking subgroup of the Swiss National Science 
Foundation-supported Cohort Study on Substance Use and 
Risk Factors (C-SURF). This cohort is a population-based 
sample of young Swiss men in their mid-20s (n=2668). 
The sample size calculation is based on a proportion 
non-inferiority test (alpha=5%, power=80%, margin of 
equivalence=10%, difference in sensitivity between self-
reported AUD and HAU=5%, correlation between AUD and 
HAU=0.35, and drop-outs=15%). Assessment will include 
a clinical interview as the gold standard of alcohol-related 
dependence, self-reported alcohol measures (HAU, AUD 
and drinking patterns), biomarkers as gold standards 
of chronic excessive drinking, and health outcomes. To 
assess the validity of the self-reported alcohol measures, 
sensitivity analyses will be run. The associations between 
alcohol-related measures and health outcomes will 
be tested. A non-response analysis will be run using 
the previous waves of the C-SURF study using logistic 
regressions.
Ethics and dissemination The study protocol has been 
approved by the Human Research Ethics Committee of the 
Canton of Vaud, Switzerland (no. 2017–00776). The results 
will be submitted for publication in peer-reviewed journals 
and presented at national and international conferences.
bACkground 
Substance-related dependence is a major 
health concern worldwide, with alcohol 
being described as the substance leading 
to the most disabling mental disorders.1 
Defining and measuring substance-related 
dependence is difficult and has led to various 
changes according to social, economic and 
political reasons.2 Indeed, substance-related 
dependence went through several shifts in 
terminology, definition, and measurement 
over the last 50 years.2 3 These changes were 
designed to improve its measure and aimed 
to be scientifically valid, clinically useful 
and understandable by the general public.4 
Generally speaking, there is an agreement 
to define substance-related dependence as 
a syndrome of physiological, behavioural 
and cognitive phenomena developed after 
repeated substance use.5–7 Therefore, ‘alco-
hol-related dependence’ can be defined as 
a syndrome of physiological, behavioural 
and cognitive phenomena developed after 
repeated alcohol use. We prefer this term 
instead of ‘alcohol dependence’, which would 
be misleading because alcohol dependence 
has been used to define a distinct disorder in, 
for example, in the Diagnostic and Statistic 
Manual of Mental Disorders (DSM) IV7 and 
International Classification of Diseases (ICD) 
11 and no longer exists in the DSM-5, which 
strengths and limitations of this study
 ► Evaluation of self-reported outcomes compared with 
a clinical interview based on the DSM-5.
 ► Inclusion of a large number of outcomes: clinical 
interview, biological material, and self-reported 
measures.
 ► Nested project in a longitudinal study: longitudinal 
data available for the participants included in the 
sample, non-response analysis.
 ► Only men in their mid-20s.
 ► The available data to test reliability of the self-re-
ported measures are separated by one year.
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combines two disorders, abuse and dependence, into 
alcohol use disorder (AUD).
Measuring alcohol-related dependence: the gold standard
Assessing alcohol-related dependence requires a clinical 
interview conducted by an experienced clinician in direct 
exchange with a patient. Indeed, a clinical interview 
provides a reliable diagnosis and it is often seen as a gold 
standard. Without an extensive anamnesis, it is difficult 
to establish a reliable diagnosis because alcohol-related 
dependence is a syndrome with several physiological, 
behavioural, cognitive and psychological processes, and 
not just ‘a tick box of symptoms’.8
Beyond clinical interviews, biochemical investigations 
are also used to assess chronic excessive drinking9 without 
asking people about their alcohol use. Biomarkers do 
not allow direct testing of the concept of alcohol-related 
dependence. However, they may be useful to screen for 
chronic excessive drinking, which may be a strong indi-
cator of alcohol-related dependence. Since they do not 
rely on self-reports nor judgements of a clinician, they are 
of great interest in alcohol research.
However, clinical diagnoses and biomarker analyses are 
costly and time consuming and therefore not suitable for 
general population assessments that are needed for public 
health planning and monitoring, such as establishing 
prevalence rates, treatment planning, policy-making, and 
early intervention. Therefore, short quantitative measures 
of alcohol-related dependence are needed.
Alcohol-related dependence self-reported measures
Several self-reported measures of alcohol-related depen-
dence are already available. In the recent developments 
of the DSM-5, alcohol-related dependence is measured 
through eleven criteria designed to diagnose AUD.10 
However, despite the fact that AUD is well defined and 
that its measure addresses previous issues related to the 
diagnosis of the DSM-IV,11 several studies reported diffi-
culties related to alcohol-related dependence’s measure-
ment using self-reported measures (eg, refs 12–14). For 
example, the self-reported questions based on the criteria 
of AUD10 may be misinterpreted by respondents. Previous 
studies highlighted misinterpretation of DSM diagnostic 
criteria,13 15 contamination by negative thinking patterns 
of depressive people,16 lack of specificity,14 low positive 
predictive values (meaning that those who screen positive 
do not have the disorder),17 and lack of convergence with 
clinical diagnoses.5 Young heavy drinkers are especially 
concerned. They are likely to misinterpret survey ques-
tions and to share a misperception of AUD symptoms, 
such as after-effects and acute intoxication. Therefore, 
they are likely to over-report physiological symptoms of 
withdrawal and tolerance.12 Moreover, it seems that 
self-reports are not always consistent with clinical diag-
noses. However, misspecification of self-reported AUD is 
understudied.12
As a consequence of these pitfalls, a recent study called 
for more evidence-based measures.2 Some previous 
studies proposed heavy use as a suitable criterion in future 
classifications of substance-related dependence.2 18 19 
Rehm et al2 suggested that alcohol use over time, and 
more specifically heavy alcohol use (HAU) over time, 
is responsible for the physiological changes, symptoms, 
social consequences and burden of disease associated 
with the current definition of alcohol-related depen-
dence. They concluded that HAU should be a relevant 
indicator of alcohol-related dependence. Moreover, the 
use of HAU also may diminish stigmatisation associated 
with alcohol-related dependence5 18 20 21 since alcohol 
use over time is less stigmatised than AUD. However, 
there are at least two important issues. The first one 
is the lack of definition of HAU: how many drinks are 
needed to defined ‘heavy use’, and how many months are 
needed to define ‘over time’? Currently, some indicators 
of alcohol use over time are available; for example, two 
drinks per day maximum is defined as low-risk alcohol 
consumption.22 Second, some studies reported that HAU 
is not a sufficient indicator of addictive behaviour,23 but 
empirical studies investigating this question using reliable 
measures of alcohol-related dependence have not been 
conducted. This measure does not aim to replace clinical 
assessments, which are compulsory for diagnostic evalu-
ation and treatment, but would be of great interest for 
general population screening purposes. Thus, there is 
still a lack of consensus on which measure should be used 
and of empirical studies designed to test its reliability.
An alternative operationalisation of alcohol-related 
dependence has recently been suggested by Martin et al.24 
They proposed that substance use disorders should focus 
on what they called ‘core’ features (ie, primary symptoms 
indexing internal dysfunctions) and not on ‘ancillary’ 
features (ie, consequences). According to these authors, 
consequences should not be used to measure substance-re-
lated dependence because they are context dependent, 
manifoldly determined and not necessarily related to 
one substance but to multiple substances. It is well estab-
lished that AUD is associated with several detrimental 
consequences as consequences are part of the DSM-5 
definition. However, non-disordered AUD can also result 
in consequences.14 Therefore, Martin et al24 suggested 
assessing alcohol-related dependence with primary symp-
toms and removing consequences from its measure in 
order to get a more reliable measure; for example, to 
decrease the number of false negatives. To our knowl-
edge, no empirical study tested this proposition, and data 
are thus needed.
Aim of the study
Based on clinical interviews designed to diagnose alco-
hol-related dependence, the main aim of this study is to 
test the quality of self-reported AUD to assess alcohol-re-
lated dependence in the general population. Another 
aim of this study is to test whether self-reported HAU 
can be used instead of self-reported AUD as a measure 
of alcohol-related dependence in a general popula-
tion-based sample. It will also test whether self-reported 
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AUD focusing on primary symptoms and excluding alco-
hol-related consequences is a better assessment of alco-
hol-related dependence than self-reported AUD in its 
traditional definition.
MEthods/dEsIgn
study design
The study is a single-centre, national, controlled study 
with a stratified random sample selection and a cross-sec-
tional design.
setting
The study will be conducted in the Lausanne University 
Hospital (CHUV) in the Alcohol Treatment Centre. This 
facility is an urban public hospital serving 770 000 people. 
It is one of the five teaching university hospitals located 
in Switzerland.
Population and sample
Population
Our study is a large nested project of the ongoing longi-
tudinal Cohort Study on Substance Use and Risk Factors 
(C-SURF) study supported by the Swiss National Founda-
tion (SNF grant 33CSC0_122679, 33CSC0_139467 and 
33CS30_148493).25 The C-SURF study is representative of 
young men around 20 years old. Young men are the study 
focus because they are a high-risk population regarding 
alcohol use.26 In collaboration with the C-SURF study, 
participation in the present project will be proposed to all 
French-speaking participants who were recruited within 
the Lausanne army recruitment centre and who answer the 
second follow-up of C-SURF in the following six months 
with a valid email address (n=2668). French speakers 
are the targets of this study because C-SURF covered all 
French speakers, whereas the German-speaking part uses 
only a subgroup of all German-speaking Swiss men. To 
focus on French speakers also reduces costs by using only 
one language for clinical assessment and a narrower area 
from which people have to travel for the clinical interview. 
In addition, C-SURF collected extensive data, and there-
fore additional detailed information about participants 
for the present project will be available. C-SURF also 
provides an up-to-date address registry and a tracking 
team, which will be useful to keep drop-out rates low.
Recruitment
First, all French-speaking men involved in the C-SURF 
study on 25 September 2017 with a valid email address 
have been invited by email to complete a ten-question 
online version of the Alcohol Use Disorder Identification 
Test (AUDIT) (five min)27 28 and have been informed 
that they may be contacted for the whole study if they are 
selected within the following six months. A second email 
was sent two weeks later to the participants who did not 
answer the questionnaire.
Second, we will select participants using a random strat-
ified sample selection. All the participants who complete 
the AUDIT and meet the inclusion criteria (see below) 
will be separated in two strata (AUDIT ≥13; AUDIT <13), 
called groups hereafter. A total of 173 participants will be 
selected in the first group and 107 in the second group, 
using randomised numbers with the software R.
Selected participants will be contacted by phone by the 
psychologists to invite them to participate in the clinical 
assessment. An appointment at the CHUV will be sched-
uled if a participant agrees to participate. The whole 
procedure of recruitment is presented in figure 1.
Procedure
During assessment in the CHUV, participants will 
complete a computer-assisted questionnaire. Then, they 
will participate in the structured interview with a psychol-
ogist. Biological samples will be collected afterwards. The 
visit will take 90 min on average. The participants will be 
blinded to the group to which they belong. The inter-
viewers will also be blinded to the participants’ group. 
The participant will be given an oral feedback on their 
alcohol use after the interview and a written feedback at 
the end of the study.
Inclusion/exclusion criteria
This study is nested in the C-SURF study, of which the 
inclusion criteria were:
Figure 1 Flow diagram and timetable for the selection of study participants. 
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 ► All young Swiss men at the army recruitment centre 
of Lausanne.
 ► All French-speaking cantons of Switzerland are 
included.
Within the French-speaking participants of the C-SURF, 
participants of the present study will be eligible if:
 ► They have a valid email address.
 ► They completed the AUDIT.
 ► They are randomly selected for the study’s 
participation.
The exclusion criteria of our study are the following:
 ► They do not provide an informed consent to partici-
pate in the study.
 ► They have a score of zero on the three first questions 
of the AUDIT questionnaire related to alcohol use 
during the previous twelve months.
hypotheses and research questions
Primary outcomes
Hypothesis 1
Self-reported AUD is not a reliable measure of alcohol-re-
lated dependence.
Hypothesis 2
HAU is a reliable measure of alcohol-related dependence.
Secondary outcomes
We also aim to investigate important secondary questions 
related to AUD and drinking patterns, as follows.
Research question 1
This question is related to the pattern of alcohol use and 
its relationship with alcohol-related dependence. Risky 
single-occasion drinkers, drinkers who drink six or more 
drinks on a single occasion, are more likely to be clas-
sified with alcohol-related dependence than non-risky 
single-occasion drinkers. We hypothesise that for the 
same moderate level of alcohol use, risky single-occasion 
drinking (RSOD) will be associated with a higher level of 
alcohol-related dependence, since this drinking pattern 
has been described as harmful.28–31 For example, people 
who drink seven drinks on Friday and Saturday (total 
14 drinks per week) will have a higher level of alcohol 
dependence than people who drink three drinks on four 
different days (total 14 drinks per week). This hypothesis 
applies for moderate drinking levels because those who 
drink heavily are probably risky single-occasion drinkers 
(eg, five drinks per day). We also hypothesise that RSOD 
will also be associated with increased self-reported AUD.32
Research question 2
The second question deals with cut-offs for the biomarkers 
of chronic excessive drinking. More investigations are 
needed in order to propose relevant cut-offs for (ethyl 
glucuronide (EtG)) in hair and PEth (phosphatidyleth-
anol (PEth)) in blood. Evidence is still needed to define 
unhealthy alcohol use for decision-making. We will test 
the diagnostic performance of EtG and PEth compared 
with the clinical interviews. We will also test whether EtG 
and PEth are potential measures of RSOD, which is a 
question that has not been yet at focus, even if RSOD is a 
common drinking pattern among young people.
Research question 3
Another transversal research question will be to inves-
tigate non-response bias. Non-response bias is a crucial 
issue in surveys focusing on substance use. Indeed, 
contrariwise to most of the studies in which information 
about non-respondents are generally unavailable, data 
about the population (ie, C-SURF participants) will be 
available (eg, self-reported alcohol use, AUD, alcohol-re-
lated consequences, non-alcohol-related consequences, 
and mental and physical health). Therefore, we will be 
able to estimate non-response bias and predictors of 
non-response among participants who will be contacted 
to participate in the present study.
Endpoint
Primary endpoints
1. Alcohol-related dependence: Alcohol-related depen-
dence will be assessed using a clinical interview over 
a twelve-month period. This diagnosis, our gold stan-
dard, will be based on the Diagnostic Interview for 
Genetic Studies (DIGS).33 It enables a comprehensive 
assessment of alcohol-related dependence and gener-
ates reliable diagnoses. It allows for the assessment of 
a comprehensive psychiatric diagnosis of alcohol-re-
lated dependence based on DSM-5 criteria. Its semi-
structured format ensures homogeneity across patients 
and interviewers. We will add three questions related 
to craving.34 Craving was added in the DSM-5, and the 
DIGS is available only according to the DMS-IV defini-
tion of alcohol-related dependence.
2. AUD: We will measure AUD as defined in the DSM-5, 
with eleven criteria.10 We will use the cut-offs recom-
mended in the DSM-5 to define presence or absence of 
AUD (ie, two criteria out of eleven criteria), and also a 
continuous scale of criteria (from 0 to 11, with a sum 
score of the eleven criteria). Moreover, following Mar-
tin et al,24 a restricted definition of primary symptoms 
of AUD will be computed by summing the items relat-
ed to internal dysfunction (six criteria). We will use a 
continuous scale of criteria, since no cut-off is available 
for this operationalisation.
3.  Alcohol use over time: Alcohol use over time will be 
measured with an extended quantity–frequency (QF) 
questionnaire. The extended QF questionnaire cap-
tures the variability in drinking habits better than 
with other instruments,35 providing separate infor-
mation on weekends and weekdays over a period of 
time (twelve months in our study). The measures are 
converted into a total number of drinks per week by 
multiplying average frequency of drinking and quan-
tity of drinking. In order to define HAU, we will test 
different cut-offs (eg, the traditional cut-offs of two 
and four drinks on average per day and empirical cut-
offs).
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4.  Number of drinks according to past-week diary: The 
number of drinks during the past week assessed for 
each day separately will be added to create a total num-
ber of drinks for the whole week. A short-term recall 
measure (seven-day diary) will ask for the number of 
drinks during the past week on each day separately. 
This measure allows testing whether participants drink 
every day and how many drinks per day they drink.
5. Retrospective alcohol use: We will also collect more 
information on alcohol use over time using retrospec-
tive questions for participants at ages 10–15, 20 and 25 
using questions used in the European Investigation 
into Cancer and Nutrition study, which described the 
trends of self-reported past consumption of alcohol 
use.36 Retrospective alcohol use will be modified to 
create an average number of drinks per week at ages 
10–15, 20 and 25. This measure will provide informa-
tion on alcohol use over time.
6.  Biomarkers of chronic excessive drinking: We will use 
the EtG in hair and the PEth in whole capillary blood. 
Two locks of hair (alternatively arm/chest hair) will be 
collected to assess EtG, and a capillary blood sample on 
a dried blood spot will be taken to measure PEth. Both 
biomarkers will be analysed by liquid chromatogra-
phy coupled to tandem mass spectrometry using ISO-
validated methods (ISO: International Organization 
for Standardization). EtG and PEth are two recent bio-
markers that appear especially reliable,9 37 38 whereas 
traditional biomarkers (carbohydrate-deficient trans-
ferring and gamma-glutamyltransferase) lack sensitiv-
ity and/or specificity, especially among young people 
showing a typical RSOD behaviour on weekends or 
special occasions. Hair EtG is efficient to detect alco-
hol abuse and cut-offs have been proposed for at-risk 
drinkers (>20/30 g of ethanol/day) and heavy drink-
ers (>60 g of ethanol/day). Its sensitivity and specificity 
are very high (>95%). On the contrary, it is less reliable 
for low levels of alcohol use. By contrast, PEth is use-
ful to detect low levels of alcohol use during the last 
2–4 weeks. Indeed, PEth has demonstrated a very high 
specificity (theoretically 100%).
Secondary endpoints
1.  RSOD: RSOD is often measured with an ordinal scale 
(eg, ‘no RSOD’, ‘less than monthly RSOD’, ‘monthly 
RSOD’, ‘weekly RSOD’ and ‘daily RSOD’) and with a 
cut-off of five or six drinks on a single occasion.39 The 
current study will propose more precise operationali-
sation of RSOD (eg, number of drinks per occasion, 
duration of each occasion and continuous scale for 
number of occasions).
2. Health issues and illnesses: The Short-Form Health Sur-
vey40 will be included with its two subscales: the mental 
component summary (mental and social health) and 
physical component summary (physical health).
3. Consequences: Sixteen consequences already used 
in C-SURF, which are not explicitly substance relat-
ed,41 will be selected from standard instruments.42–45 
Two sum-scores of consequence-associated scores will 
be computed: the first for social consequences and 
the second for health consequences. In addition, al-
cohol-related consequences will be assessed as in the 
DSM-5.
4. Quality of life (QOL): WHO Quality of Life Instru-
ment-BREF has been validated widely, and it was found 
to be reliable and valid for use among patients with 
alcohol-related dependence.46 There are 26 questions 
rated on a five-point scale composed of two general 
question of QOL and four dimensions: physical health 
(seven items), psychological health (six items), social 
relationships (three items) and environment (eight 
items). Each question was rated in reference to the last 
two weeks. A percentage rating within each domain is 
computed with scores ranging from 0 (lowest QOL) to 
100 (highest QOL).
5. Life satisfaction: The Satisfaction With Life Scale 
(SWLS) will be use to assess life satisfaction.47 A 
mean score of the five questions of the SWLS will be 
computed.
Other variables
For the selection of participants, we will use the AUDIT.26 27 
The AUDIT is a ten-item screening measure for AUD48 49 
developed by the WHO, which includes three questions 
on dependence, four questions on specific consequences 
of harmful alcohol use and three questions on hazardous 
alcohol use. It has been described as a reliable screening 
tool of AUD.50
We will also assess demographic variables: age, educa-
tional status, and professional status.
Based on the C-SURF data (three waves already 
collected and available), we will match information on 
demographics, health, and substance use.
Ethical aspects and safety
Consent and risks
All procedures performed in studies involving human 
participants will be in accordance with the ethical stan-
dards of the institutional and/or national research 
committee and with the 1964 Declaration of Helsinki and 
its later amendments or comparable ethical standards. 
There is no expected adverse event or side effect for 
participants. Informed consent will be obtained from all 
individual participants included in the study.
Confidentiality of the data
Data generation, transmission, storage and analysis of 
health-related personal data and the storage of biological 
samples within this project will strictly follow the current 
Swiss legal requirements for data protection and will be 
performed according to the Human Research Ordinance 
(HRO) Art 5. Data protection and confidentiality will be 
guaranteed.
Patient and public involvement
Patients and public were not involved.
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statistical analysis
Sample size
There is no available information about the psychometric 
properties of the self-reported AUD nor of HAU. There-
fore, it was not possible to estimate a precise sample size 
in a power calculation. To ensure that we have enough 
alcohol-related dependent participants to test the hypoth-
esis of HAU being equivalent or better than self-reported 
AUD, we made several sample size calculations based on 
different scenarios of possible sensitivity of self-reported 
AUD (sensitivity between 0.2 and 0.8) using a proportion 
non-inferiority test with alpha=5%, a margin of equiva-
lence of 10% and a difference in sensitivity between 
self-reported AUD and HAU of 5%.51 The worst scenario 
is for sensitivity around 50% and no correlation between 
self-reported AUD and HAU. In this worst scenario, for 
a power of 80%, 135 alcohol-related dependent partic-
ipants are needed (as shown in figure 2). In a favour-
able scenario, with a power of 80% and a middle/large 
correlation (supported by the C-SURF data: r=0.50), a 
total of 67 participants with alcohol-related dependence 
are needed. We decided to choose a scenario between the 
worst and the most favourable with a correlation between 
self-reported AUD and HAU of 0.35, which is a moderate 
correlation between two related but different concepts. 
In this scenario, 86 participants with alcohol-related 
dependence are needed. Therefore, we will select at least 
86 participants with alcohol-related dependence and 86 
participants without alcohol-related dependence.
The AUDIT score will be used to select participants. 
Alcohol-related dependence is defined with a cut-off of 
13 at AUDIT,52 with a sensitivity ranging between 0.78 
and 0.90 and a specificity ranging between 0.87 and 
0.92.50 52 The positive predictive values were estimated 
between 0.40 and 0.88.50 52 Thus, by randomly selecting 
151 participants with AUDIT greater or equal to 13 and 
a positive predicted value of 0.64 (midpoint between 
0.40 and 0.88), there is a 95% probability of selecting at 
least 86 participants who are true positive. The negative 
predictive values were estimated at 0.97.50 52 Therefore, 
we will select 93 participants with AUDIT lower than 13 
in order to have a 95% probability of selecting at least 86 
true negative non-alcohol-dependent participants. The 
psychologists will be blinded to the participants’ AUDIT 
scores. In order to avoid issues related to attrition, we 
added 15% of participants in each group, a total of 173 
participants with AUDIT ≥13 and 107 participants with 
AUDIT <13 will be invited in each group (n=280).
Data analyses
Analyses 1 (primary outcomes): HAU and AUD as measures of 
alcohol-related dependence
Considering the clinical interviews as a gold standard of 
alcohol-related dependence, and biomarkers as a gold 
Figure 2 Proportion non-inferiority test. 
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standard of chronic excessive drinking, we will test the 
diagnostic performance of self-reported AUD and HAU 
measures to see whether they are suitable ways to assess 
alcohol-related dependence. We will use effect sizes to 
compare the correlations (R2 to test common variance 
between measures and clinical effect size), and we will use 
Fisher’s R to Z transformations to compare whether the 
correlations are significantly different from one another. 
Then, we will use dichotomised variables and test sensi-
tivity, specificity, positive predicted value, and negative 
predicted value using the receiver operating character-
istic (ROC) curves. To dichotomise alcohol use, different 
theory-oriented cut-offs will be compared (four, two and 
one drink(s) per day), and data-driven models will also be 
tested using stratum-specific likelihood ratio analysis and 
machine learning (random forests).
Analyses 2 (primary and secondary outcomes): associations with 
health outcomes and alcohol-related variables
We will compare outcomes’ associations with the gold 
standards and the different self-reported measures 
(HAU, self-reported AUD and self-reported AUD without 
consequences). Effect sizes will be compared in order to 
know which measure is the best predictor of health and 
psychosocial issues and which one most resembles the 
associations with the gold standards.
Analyses 3 (secondary research question): association of RSOD 
with alcohol-related dependence
Associations of RSOD with the gold standard of alcohol-re-
lated dependence will be performed, adjusting for alcohol 
use (extended QF questionnaire) to assess its indepen-
dent effect, and including an interaction between alcohol 
use and RSOD to investigate their combined effect.
Analyses 4 (secondary research question): cut-off for biomarkers 
and associations with RSOD
The diagnostic performance of EtG and PEth will be 
calculated for their optimal cut-off values selected with 
the ROC curves. Comparisons with clinical interviews, 
and HAU will be performed. We will also test whether 
EtG and PEth are potential measures of RSOD, using 
EtG and PEth cut-offs to predict RSOD using correlations 
and ROC curves. Different cut-offs will be tested in these 
analyses.
Analyses 5 (secondary research question): non-response bias
We will compare non-respondents to respondents using 
the information available in the previous waves of the 
C-SURF study using logistic regressions.
All analyses will use a two-sided α=0.05. Statistical soft-
ware will include SPSS V.24, Stata V.15 and R.
dIsCussIon
The main aim of this study is to test the quality of the 
self-reported AUD (also focusing on primary symptoms 
and excluding alcohol-related consequences) and of 
the self-reported HAU as measures of alcohol-related 
dependence as defined by the DSM-5 in a general popu-
lation. The psychometric properties of the self-reported 
AUD and of the HAU will be tested against a clinical inter-
view designed to diagnose alcohol-related dependence.
From an international perspective, the proposed project 
aims to address some methodological issues highlighted 
in recent studies related to the measure of substance-re-
lated dependence, and more specifically, alcohol-re-
lated dependence. The project will provide evidence 
regarding two important issues. First, it will test whether 
self-reported AUD, which is extensively used in alcohol 
research, is a reliable way to assess alcohol-related depen-
dence. Second, it will investigate whether HAU is a reli-
able measure of alcohol-related dependence. Therefore, 
the study will provide insights on its capacity to capture 
alcohol-related dependence. The results of the study may 
have a large impact on future research on alcohol. It will 
suggest a better way to assess alcohol-related dependence 
in population-based samples and for screening perspec-
tives. Additionally, the project will investigate thresholds 
needed for decision-making (early intervention and 
treatment), test the effect of drinking patterns on self-re-
ported AUD, and determine cut-offs for biomarkers. 
These cut-offs will be useful for legal medicine, which 
needs further studies for decision-making regarding 
alcohol abstinence.
From a national perspective, this study will provide a 
valid prevalence rate of alcohol-related dependence 
among French-speaking young Swiss men in their mid-20s. 
It will be useful from a public health point of view. More-
over, cut-offs for unhealthy alcohol use will be proposed, 
which may be relevant for preventive purposes and may 
identify at-risk youths in Switzerland. It will improve 
screening for unhealthy alcohol use. It would also be 
useful for general practitioners to detect alcohol-related 
dependent persons.53
The current study is designed to provide evidence 
regarding the assessment of alcohol-related dependence 
in the general population and especially among young 
people. Potential benefits to society include a better 
understanding and evaluation of alcohol-related depen-
dence, improvements of practices and future develop-
ment of adequate public health planning. It will help to 
identify at-risk persons and groups. It may change the 
practices from a clinical and public health perspective, 
such as the use of alternative measures to screen for alco-
hol-related dependence and identify at-risk alcohol users, 
and from a research perspective, for example, to stop 
using unreliable self-reported addiction scales and thus 
to provide strong support to future findings in alcohol 
research.
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